GB9727512D0 - Fuzzy genes and their application in molecular adjuvants - Google Patents

Fuzzy genes and their application in molecular adjuvants

Info

Publication number
GB9727512D0
GB9727512D0 GBGB9727512.7A GB9727512A GB9727512D0 GB 9727512 D0 GB9727512 D0 GB 9727512D0 GB 9727512 A GB9727512 A GB 9727512A GB 9727512 D0 GB9727512 D0 GB 9727512D0
Authority
GB
United Kingdom
Prior art keywords
concatamer
encode
sequences
dna
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9727512.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adprotech PLC
Original Assignee
Adprotech PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adprotech PLC filed Critical Adprotech PLC
Priority to GBGB9727512.7A priority Critical patent/GB9727512D0/en
Publication of GB9727512D0 publication Critical patent/GB9727512D0/en
Priority to US09/582,761 priority patent/US6770631B1/en
Priority to EP98962638A priority patent/EP1042467B1/en
Priority to JP2000527645A priority patent/JP2002500042A/ja
Priority to CA002317020A priority patent/CA2317020A1/en
Priority to NZ505827A priority patent/NZ505827A/xx
Priority to DE69839848T priority patent/DE69839848D1/de
Priority to AT98962638T priority patent/ATE403721T1/de
Priority to PCT/GB1998/003918 priority patent/WO1999035260A1/en
Priority to AU17762/99A priority patent/AU757021B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
    • C07K2319/92—Fusion polypeptide containing a motif for post-translational modification containing an intein ("protein splicing")domain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
GBGB9727512.7A 1997-12-31 1997-12-31 Fuzzy genes and their application in molecular adjuvants Ceased GB9727512D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB9727512.7A GB9727512D0 (en) 1997-12-31 1997-12-31 Fuzzy genes and their application in molecular adjuvants
AU17762/99A AU757021B2 (en) 1997-12-31 1998-12-30 Non-identical genes and their application in improved molec ular adjuvants
CA002317020A CA2317020A1 (en) 1997-12-31 1998-12-30 Non-identical genes and their application in improved molecular adjuvan ts
EP98962638A EP1042467B1 (en) 1997-12-31 1998-12-30 Non-identical genes and their application in improved molecular adjuvants
JP2000527645A JP2002500042A (ja) 1997-12-31 1998-12-30 非同一遺伝子ならびに改良された分子アジュバントにおけるそれらの適用
US09/582,761 US6770631B1 (en) 1997-12-31 1998-12-30 Non-identical genes and their application in improved molecular adjuvants
NZ505827A NZ505827A (en) 1997-12-31 1998-12-30 Concatamers of non-identical genes for the same polypeptide and their application in vaccines
DE69839848T DE69839848D1 (de) 1997-12-31 1998-12-30 Nicht identische gene und ihre anwendung in verbesserten molekularen adjuvanten
AT98962638T ATE403721T1 (de) 1997-12-31 1998-12-30 Nicht identische gene und ihre anwendung in verbesserten molekularen adjuvanten
PCT/GB1998/003918 WO1999035260A1 (en) 1997-12-31 1998-12-30 Non-identical genes and their application in improved molec ular adjuvants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9727512.7A GB9727512D0 (en) 1997-12-31 1997-12-31 Fuzzy genes and their application in molecular adjuvants

Publications (1)

Publication Number Publication Date
GB9727512D0 true GB9727512D0 (en) 1998-02-25

Family

ID=10824333

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9727512.7A Ceased GB9727512D0 (en) 1997-12-31 1997-12-31 Fuzzy genes and their application in molecular adjuvants

Country Status (10)

Country Link
US (1) US6770631B1 (enExample)
EP (1) EP1042467B1 (enExample)
JP (1) JP2002500042A (enExample)
AT (1) ATE403721T1 (enExample)
AU (1) AU757021B2 (enExample)
CA (1) CA2317020A1 (enExample)
DE (1) DE69839848D1 (enExample)
GB (1) GB9727512D0 (enExample)
NZ (1) NZ505827A (enExample)
WO (1) WO1999035260A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008582D0 (en) * 2000-04-08 2000-05-31 Adprotech Plc DNA immunization vectors
WO2001092295A2 (en) * 2000-05-30 2001-12-06 University Of Toronto Ligands for cd21 and compositions thereof for modulating immune responses
GB0025229D0 (en) * 2000-10-14 2000-11-29 Adprotech Ltd Veterinary immunisation vectors
US7838287B2 (en) 2001-01-25 2010-11-23 Evolva Sa Library of a collection of cells
US8008459B2 (en) 2001-01-25 2011-08-30 Evolva Sa Concatemers of differentially expressed multiple genes
KR100453877B1 (ko) 2001-07-26 2004-10-20 메덱스젠 주식회사 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
GB0204154D0 (en) * 2002-02-22 2002-04-10 Adprotech Ltd Cat immunisation vectors
CA2494971A1 (en) * 2002-08-14 2004-02-26 Avidis Sa Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use
US7664748B2 (en) * 2004-07-12 2010-02-16 John Eric Harrity Systems and methods for changing symbol sequences in documents
EP1910827A4 (en) * 2005-07-15 2010-02-03 Novartis Ag MOLECULAR MOTIVES ASSOCIATED WITH PATHOGENS (PAMP)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01501755A (ja) * 1986-11-04 1989-06-22 シントロ　コーポレイション 合成ｄｎａの構成および大ポリペプチドの合成におけるその使用
US6018030A (en) * 1986-11-04 2000-01-25 Protein Polymer Technologies, Inc. Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
US5641648A (en) * 1986-11-04 1997-06-24 Protein Polymer Technologies, Inc. Methods for preparing synthetic repetitive DNA
JPH0829098B2 (ja) * 1988-01-05 1996-03-27 寳酒造株式会社 細胞接着活性ポリペプチド
AU3274793A (en) * 1991-12-12 1993-07-19 Hybritech Incorporated Enzymatic inverse polymerase chain reaction library mutagenesis
US5861285A (en) * 1994-09-16 1999-01-19 Tdk Corporation Fusion protein-bound magnetic particles for recombinant production and magnetic separation of polypeptides of interest
US5763733A (en) * 1994-10-13 1998-06-09 Enzon, Inc. Antigen-binding fusion proteins
GB9424631D0 (en) * 1994-12-06 1995-01-25 Lynxvale Ltd Modulating the immune response
DE19756975A1 (de) * 1997-12-20 1999-06-24 Hoechst Marion Roussel De Gmbh Bindungspartner für Inhibitoren von cyclinabhängigen Kinasen und ihre Verwendung zur Suche nach Inhibitoren, zur Diagnose oder zur Therapie einer Erkrankung

Also Published As

Publication number Publication date
AU1776299A (en) 1999-07-26
JP2002500042A (ja) 2002-01-08
NZ505827A (en) 2003-03-28
AU757021B2 (en) 2003-01-30
CA2317020A1 (en) 1999-07-15
US6770631B1 (en) 2004-08-03
EP1042467B1 (en) 2008-08-06
EP1042467A1 (en) 2000-10-11
DE69839848D1 (de) 2008-09-18
ATE403721T1 (de) 2008-08-15
WO1999035260A1 (en) 1999-07-15

Similar Documents

Publication Publication Date Title
FR19C1020I1 (fr) Nouvelles molecules b7-4 et leurs utilisations
ATE386800T1 (de) Immunogene chimäre umfassend nucleinsäuresequenzen, die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
EP0722461A4 (en) EXPRESSION OF FUSION POLYPEPTIDES TRANSPORTED OUT OF CYTOPLASM WITHOUT HEAD SEQUENCE
NO179253C (no) Rekombinant DNA-sekvens som koder for humant proapolipoprotein A-I, ekspresjonsvektorer, cellekulturer samt fremgangsmåte for fremstilling av proteinet
ATE184052T1 (de) Gdf-1 und uog1 proteine
GB9727512D0 (en) Fuzzy genes and their application in molecular adjuvants
DK0587742T3 (da) Vitaminafhængig carboxylase
ATE346931T1 (de) Clostridium perfringens impfstoff
IE811049L (en) Cloned fmdv antigens
NO902251L (no) Fremstilling av gonoreiske p1-proteiner og vaksiner.
HUP0100267A2 (hu) Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények
WO2000012535A3 (en) Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
GR3023593T3 (en) Protein structure of the plant toxin gelonin
DE60143029D1 (de) M necrophorum und dessen präparation
GB9215232D0 (en) Vaccines
JP2002500042A5 (enExample)
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
DK551786D0 (da) Rekombinant-dna-sekvens, der koder for aminosyresekvenser i et toksin, expressionssystem omfattende samme og vaertsceller transformeret hermed
EP0367641A3 (en) Lymphokines, dna sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines
IL78278A0 (en) Process for the production of polypeptides,dna sequence encoding desired polypeptide human somatomedin c polypeptide and recombinant dna molecules
BR0012740A (pt) Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego
ATE474927T1 (de) Schützende hochmolekulargewichtsproteine aus haemophilus influenzae
WO2002029041A3 (en) 32146 and 57259, novel human transporters and uses thereof
EP1314785A4 (en) NUCLEIC ACIDS AND PROTEINS WITH INCREASED EXPRESSION LEVELS UNDER THE EFFECT OF SALT-DRIVEN STRESS
WO2003008621A3 (en) 87144, human amino acid transporter family member and uses therefor

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)